Drug Company Leaders Condemn Ruling Invalidating F.D.A.’s Approval of Abortion Pill

NYT HEALTH: Drug Company Leaders Condemn Ruling Invalidating F.D.A.’s Approval of Abortion Pill
By Pam Belluck and Christina Jewett
Section: Health
Source: New York Times
Published Date: April 10, 2023 at 03:00AM

More than 400 executives said that the decision ignored both scientific and legal precedent and that, if the ruling stood, it would create uncertainty for the pharmaceutical and biotech industries.

The pharmaceutical industry plunged into a legal showdown over the abortion pill mifepristone on Monday, issuing a scorching condemnation of a ruling by a federal judge that invalidated the Food and Drug Administration’s approval of the drug and calling for the decision to be reversed.
The statement was signed by more than 400 leaders of some of the drug and biotech industry’s most prominent investment firms and companies, none of which make mifepristone, the first pill in the two-drug medication abortion regimen. It shows that the reach of this case stretches far beyond abortion. Unlike Roe v. Wade and other past landmark abortion lawsuits, this one could challenge the foundation of the regulatory system for all medicines in the United States.
“If courts can overturn drug approvals without regard for science or evidence, or for the complexity required to fully vet the safety and efficacy of new drugs, any medicine is at risk for the same outcome as mifepristone,” said the statement.

Read more: https://www.nytimes.com/2023/04/10/health/abortion-ruling-pharma-executives.html